SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-000238
Filing Date
2024-01-02
Accepted
2024-01-02 16:01:09
Documents
12
Period of Report
2023-12-26
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K scyx-20231226.htm   iXBRL 8-K 44571
  Complete submission text file 0000950170-24-000238.txt   162549

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scyx-20231226_lab.xml EX-101.LAB 13352
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scyx-20231226_pre.xml EX-101.PRE 9843
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scyx-20231226.xsd EX-101.SCH 2469
6 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20231226_htm.xml XML 4706
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 24502324
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)